Related Experiment Videos

Muscular dystrophy meets the gene chip: new insights into disease pathogenesis

J S Chamberlain¹

¹Department of Neurology, University of Washington School of Medicine, Seattle, Washington 98195, USA.

The Journal of Cell Biology

|December 21, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction.

Gene therapy·2012

Microarchitecture is severely compromised but motor protein function is preserved in dystrophic mdx skeletal muscle.

Biophysical journal·2010

Unloaded speed of shortening in voltage-clamped intact skeletal muscle fibers from wt, mdx, and transgenic minidystrophin mice using a novel high-speed acquisition system.

Biophysical journal·2008

Gene therapy for Duchenne muscular dystrophy: AAV leads the way.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2006

Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.

Gene therapy·2005

Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle.

Human molecular genetics·2003

See all related articles